title: Available resources and challenges for the clinical annotation of somatic variations.
abstract: Next-generation sequencing (NGS) has become an important tool for identifying clinically relevant variants in both inherited disorders and oncology. Variants annotation that enables the creation of meaningful clinical reports often requires mining multiple publicly available databases. There are a number of such resources that have been designed to catalog and mine a plethora of germline variants or mutations. However, when analyzing tumor specimens in clinical settings, one may need to use different or ancillary resources that are specific for somatic variants or actionable mutations that may have clinical or treatment implications. The purpose of this review is to recapitulate the state of the art of somatic variation databases, which can aid in the clinical interpretation of NGS-based assays in oncology. In addition, the current need for collating various annotation sources into one-stop solutions to facilitate faster query execution and better integration into existing laboratory information systems are discussed.
authors.affiliation: Department of Pathology, Virginia Commonwealth University, Richmond, Virginia.
authors.forename: Catherine I
authors.initials: CI
authors.lastname: Dumur
mesh_terms: D030541:Databases, Genetic; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D020022:Genetic Predisposition to Disease / Q000453:epidemiology; D014644:Genetic Variation; D015894:Genome, Human; D006295:Health Resources; D059014:High-Throughput Nucleotide Sequencing; D006801:Humans; D008297:Male; D009154:Mutation; D009369:Neoplasms / Q000175:diagnosis / Q000235:genetics*; D017422:Sequence Analysis, DNA
keywords: actionable mutations; cancer targeted therapies; clinical genomic reports; public databases; somatic variants
references.citation: Nature. 2012 Nov 1;491(7422):56-65
references.pmid: 23128226
references.citation: Nature. 2012 Mar 28;483(7391):603-7
references.pmid: 22460905
references.citation: Hum Mutat. 2000;15(1):7-12
references.pmid: 10612815
references.citation: Am J Hum Genet. 1993 Sep;53(3):783-5
references.pmid: 8352285
references.citation: Proc Am Thorac Soc. 2012 May;9(2):72-3
references.pmid: 22550248
references.citation: Brief Bioinform. 2014 Mar;15(2):256-78
references.pmid: 23341494
references.citation: Prog Tumor Res. 2014;41:1-14
references.pmid: 24727983
references.citation: Health Info Libr J. 2002 Sep;19(3):126-32
references.pmid: 12390234
references.citation: Nat Methods. 2010 Apr;7(4):248-9
references.pmid: 20354512
references.citation: Hum Mutat. 1993;2(4):245-8
references.pmid: 8401532
references.citation: Hum Genet. 2014 Jan;133(1):1-9
references.pmid: 24077912
references.citation: AMIA Jt Summits Transl Sci Proc. 2013 Mar 18;2013:156-7
references.pmid: 24303327
references.citation: Nucleic Acids Res. 2001 Jan 1;29(1):308-11
references.pmid: 11125122
references.citation: Cancer Cytopathol. 2013 Feb;121(2):61-71
references.pmid: 22887782
references.citation: Br J Cancer. 2004 Jul 19;91(2):355-8
references.pmid: 15188009
references.citation: Genet Test Mol Biomarkers. 2010 Aug;14(4):533-7
references.pmid: 20642364
references.citation: Hum Mol Genet. 2013 Oct 15;22(R1):R27-31
references.pmid: 23962721
references.citation: Cancer Discov. 2012 May;2(5):401-4
references.pmid: 22588877
references.citation: Clin Chem Lab Med. 2014 May;52(5):707-14
references.pmid: 24334431
references.citation: Bioinformatics. 2011 Aug 1;27(15):2156-8
references.pmid: 21653522
references.citation: Sci Signal. 2013 Apr 02;6(269):pl1
references.pmid: 23550210
references.citation: J Mol Diagn. 2014 Jan;16(1):11-22
references.pmid: 24220144
references.citation: Nucleic Acids Res. 2014 Jan;42(Database issue):D980-5
references.pmid: 24234437